PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 185 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,848,000 | +420.7% | 269,462 | +685.0% | 0.27% | +478.3% |
| Q2 2019 | $931,000 | +14.9% | 34,328 | +47.0% | 0.05% | 0.0% |
| Q1 2019 | $810,000 | -73.2% | 23,350 | -79.4% | 0.05% | -73.7% |
| Q3 2018 | $3,019,000 | +80.1% | 113,350 | +155.5% | 0.18% | +65.1% |
| Q2 2018 | $1,676,000 | +18522.2% | 44,372 | +23628.3% | 0.11% | +10500.0% |
| Q4 2017 | $9,000 | -10.0% | 187 | -1.6% | 0.00% | 0.0% |
| Q3 2017 | $10,000 | -28.6% | 190 | -23.1% | 0.00% | 0.0% |
| Q2 2017 | $14,000 | -67.4% | 247 | -77.5% | 0.00% | -75.0% |
| Q1 2017 | $43,000 | -65.6% | 1,100 | -75.0% | 0.00% | -77.8% |
| Q4 2014 | $125,000 | – | 4,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |